MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

why the sell-off?, page-12

  1. 184 Posts.
    I understand they are due to release results of a trial relating to development of an anti obesity drug. Could the price drop be indicating an unfavourable result?
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.